involving the region 17q 1.2 have been reported, and it has been suggested that the gene has been disrupted, leading to loss of normal function.6 7 A physical map of 2-3 Mb of the NFl region has been constructed, the translocation breakpoints have been identified, and two HTF islands have been defined. 8 9 These translocation breakpoints are 60 kb apart.'0 Several potential coding sequences have been identified in the region flanked by the two HTF islands and the translocation breakpoints (Cawthon et al, in preparation) . 1012 Very recently, two groups have independently reported the isolation of cDNA clones within what is likely to be the NFI gene itself.'3 14 The mutation rate for NFI is very high (104/allele/ generation) and around 50% of cases represent new mutations. One possible explanation for this observation is that the NFI locus may contain highly mutable sequences which may become duplicated or deleted, as is the casein Duchennemuscular dystrophy. Because most new cases of DMD are the result of DNA deletions, we decided to investigate the possibility that deletions may be associated with new mutations in NFI. We have screened a large panel of clinically well characterised, independent NF1 mutations using the DNA markers which map between the two HTF islands, using both conventional and pulsed field gel electrophoresis, and have discovered one case in which mutation to the NF1 phenotype is accompanied by deletion of DNA from the critical region.
Patients and methods
The 
Discussion
The high mutation rate in NFl has led to expectations that, as with Duchenne muscular dystrophy, a significant number of cases would prove to result from gene deletion, but the patient reported here represents the first instance of a purely molecular deletion to be found in this disorder before isolation of the gene. One case of a ring chromosome 17 with NFl showing loss of chromosomal material in the relevant region has been described.20 Two NFl patients with translocations in 17ql 1.2 have also been reported. 8 9 In the present study, we have used PFGE to study a large panel of NFl patients and, using probes derived from the region of the translocations, we have discovered this single case in a total of 90 unrelated patients in which there has apparently been a deletion of DNA. An altered fragment, approximately 90 kb smaller than the normal one, was detected using various restriction enzymes and all of the DNA probes whose positions are shown in fig 1, with the exception of IFI0. The new band is unlikely to be the result of sequence polymorphism or methylation differences, as it is detected with different restriction enzymes and has never been observed in a sample of 200 other chromosomes.
The distance between the two translocation breakpoints is about 60 kbl' and since none of the probes that map between the breakpoints (NFI-c2 and EV12) is itself deleted, the deletion cannot encompass both translocation breakpoints. The probes 17L1A, which represents the proximal HTF island (fig 1) and HIBEOJ, which is a jump from 17LIA, are not deleted and hence the deletion is excluded from the region between these two markers. The probe lFIO maps distal to the second HTF island (fig 1) but does not detect the altered fragment; therefore, the deletion must be completely within the interval bounded by the two HTF islands. None of the remaining probes that detect the altered fragment (AC5, NFl-c2, EV12, EHI, 2B/B351, 21 T315) is itself deleted. Thus, there must be a region of at least 90 kb in which none of the probes used in this study is located, but which contains the deletion. The precise definition of this region depends on the exact location of the probe loci, but apparently lies between HIBEOJ and AC5.
Since it is likely that the deletion is the cause of NFl in the patient, it must disrupt the NFl gene, either directly by causing an alteration in the expression of the gene or indirectly as a result of the loss of regulatory sequences or a disruption in the higher order structure of DNA. We are investigating the patient to define the two ends of the deletion further.
Since the completion and preparation for publication of the work described here, two groups'l3 4 have independently reported the isolation of cDNA clones that are likely to represent part of the NF1 gene itself. The gene shows a large (13 kb) transcript and appears to have other genes embedded within its introns;
deletions have been identified in three patients and an insertion of DNA in a further one. The patient described here will provide a further advance in our understanding of the range of molecular pathology found in neurofibromatosis.
